← Open Payments lookup

SOLOMON MOSHEYEV: Open Payments

NPI 1144621590 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$578 in 23 payments from 9 companies in 2025. Trend: 2023 $217 · 2024 $311 · 2025 $578

Food & beverage: $578
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc4$129
E.R. Squibb & Sons, L.L.C.5$109
Luye Pharma (USA) Ltd.3$76
Lundbeck LLC3$70
Otsuka America Pharmaceutical, Inc.3$68
Alkermes, Inc.2$66
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$22
Neurocrine BioSciences, Inc.1$21
Teva Pharmaceuticals USA, Inc.1$17

Products named: COBENFY, ERZOFRI EXTENDED-RELEASE, SPRAVATO, REXULTI, ARISTADA, INVEGA SUSTENNA, ABILIFY MAINTENA, CAPLYTA.

Industry payments across NY — which companies pay providers there.